These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 23108408)

  • 21. A role for matrix remodelling proteins in invasive and malignant meningiomas.
    Jalali S; Singh S; Agnihotri S; Wataya T; Salehi F; Alkins R; Burrell K; Navab R; Croul S; Aldape K; Zadeh G
    Neuropathol Appl Neurobiol; 2015 Feb; 41(2):e16-28. PubMed ID: 24989599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NDRG4, the N-Myc downstream regulated gene, is important for cell survival, tumor invasion and angiogenesis in meningiomas.
    Kotipatruni RP; Ferraro DJ; Ren X; Vanderwaal RP; Thotala DK; Hallahan DE; Jaboin JJ
    Integr Biol (Camb); 2012 Oct; 4(10):1185-97. PubMed ID: 22869042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-224 targets ERG2 and contributes to malignant progressions of meningioma.
    Wang M; Deng X; Ying Q; Jin T; Li M; Liang C
    Biochem Biophys Res Commun; 2015 May; 460(2):354-61. PubMed ID: 25783051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression of fatty acid metabolism-associated proteins is correlated with the prognosis of meningiomas.
    Jiang J; Lin C; Liu N; Zhang Z; Sun Y; Fang X; Qi J
    APMIS; 2013 Oct; 121(10):997-1003. PubMed ID: 23879478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of extracellular matrix-related genes in rare variants of meningioma.
    Kwon MJ; Sung CO; Kang SY; Do IG; Suh YL
    Hum Pathol; 2013 Feb; 44(2):260-8. PubMed ID: 22995327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.
    Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K
    Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the cell lines used in meningioma research.
    Ragel BT; Couldwell WT; Gillespie DL; Wendland MM; Whang K; Jensen RL
    Surg Neurol; 2008 Sep; 70(3):295-307; discussion 307. PubMed ID: 18261772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
    Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
    Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A
    Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An allele of rs619586 polymorphism in MALAT1 alters the invasiveness of meningioma via modulating the expression of collagen type V alpha (COL5A1).
    Zheng J; Pang CH; Du W; Wang L; Sun LG; Xing ZY
    J Cell Mol Med; 2020 Sep; 24(17):10223-10232. PubMed ID: 32720739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective expression of CD44 messenger RNA splice variants in four high grade human brain tumour cell lines.
    Harn HJ; Lee HS; Ho LI; Lee WH; Ding JH
    Biochem Mol Biol Int; 1994 Jul; 33(4):743-9. PubMed ID: 7526922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical study of MRP5 expression in meningiomas.
    Alexiou GA; Goussia A; Ntoulia A; Zagorianakou P; Malamou-Mitsi V; Voulgaris S; Kyritsis AP
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):825-8. PubMed ID: 23271324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway.
    Schrell UM; Rittig MG; Anders M; Kiesewetter F; Marschalek R; Koch UH; Fahlbusch R
    J Neurosurg; 1997 May; 86(5):845-52. PubMed ID: 9126901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling.
    Monleón D; Morales JM; Gonzalez-Darder J; Talamantes F; Cortés O; Gil-Benso R; López-Ginés C; Cerdá-Nicolás M; Celda B
    J Proteome Res; 2008 Jul; 7(7):2882-8. PubMed ID: 18507434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of matrix metalloproteinases, their inhibitors, and urokinase plasminogen activator in human meningiomas.
    Siddique K; Yanamandra N; Gujrati M; Dinh D; Rao JS; Olivero W
    Int J Oncol; 2003 Feb; 22(2):289-94. PubMed ID: 12527924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaplastic and atypical meningiomas express high levels of Fas and undergo apoptosis in response to Fas ligation.
    Weisberg S; Ashkenazi E; Israel Z; Attia M; Shoshan Y; Umansky F; Brodie C
    Am J Pathol; 2001 Oct; 159(4):1193-7. PubMed ID: 11583945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of integrin-alpha 3 mRNA in meningiomas and its biological significance].
    Chen J; Xu XP
    Ai Zheng; 2002 May; 21(5):526-9. PubMed ID: 12452046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-34a-3p alters proliferation and apoptosis of meningioma cells
    Werner TV; Hart M; Nickels R; Kim YJ; Menger MD; Bohle RM; Keller A; Ludwig N; Meese E
    Aging (Albany NY); 2017 Mar; 9(3):932-954. PubMed ID: 28340489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic aggressiveness in benign meningiomas with chromosomal instabilities.
    Monleón D; Morales JM; Gonzalez-Segura A; Gonzalez-Darder JM; Gil-Benso R; Cerdá-Nicolás M; López-Ginés C
    Cancer Res; 2010 Nov; 70(21):8426-34. PubMed ID: 20861191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.